Jeff Geschwind, MD – Founder of Cage Pharma A visionary in cancer drug development, Jeff Geschwind, MD founded Cage Pharma, focusing on glycolysis-targeting therapies to disrupt tumor growth. His research opens new doors in metabolic oncology. https://www.linkedin.com/in/jeff-geschwind-037200174